Herndon Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Herndon Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-22	Closed	-$3K	–	593
2016 Q2	$3K	Sell	22 -263,242	-100%	-$38.8M	﹤0.01%	326
2016 Q1	$34.4M	Sell	263,264 -720,955	-73%	-$89.7M	0.86%	42
2015 Q4	$138M	Buy	984,219 +687,100	+231%	+$95.2M	2.92%	11
2015 Q3	$39.5M	Buy	297,119 +285,183	+2,389%	+$49.1M	0.77%	43
2015 Q2	$2.1M	Buy	11,936 +6,369	+114%	+$1.14M	0.03%	76
2015 Q1	$953K	Sell	5,567 -226	-4%	-$38.8K	0.01%	123
2014 Q4	$948K	Buy	+5,793	New	+$962K	0.01%	125

Other funds holding JAZZ

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Herndon Capital Management's JAZZ Position: Q3 2016 in Review

Herndon Capital Management sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2016, closing a stake of 22 shares — an estimated $3K sold.

Herndon Capital Management first reported a position in JAZZ in Q4 2014 and held it in 7 quarters. The position peaked at $138M in Q4 2015. 325 funds tracked by Wall St. Rank hold JAZZ as of Q3 2016.

Herndon Capital Management reported no remaining Jazz Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
Herndon Capital Management sold 22 Jazz Pharmaceuticals shares in Q3 2016, an estimated $3K.
Herndon Capital Management first reported a position in Jazz Pharmaceuticals in Q4 2014 and held it in 7 quarters.
Herndon Capital Management's Jazz Pharmaceuticals position peaked at $138M in Q4 2015.
325 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2016.

Based on Herndon Capital Management's 13F filing for Q3 2016, filed 7 Nov 2016.